Kenvue Inc. (BMV:KVUE)

Market Cap	598.58B -25.7%
Revenue (ttm)	275.44B -2.9%
Net Income	26.30B +34.7%
EPS	13.72 +35.3%
Shares Out	n/a
PE Ratio	22.76
Forward PE	16.78
Dividend	15.85 (5.07%)
Ex-Dividend Date	Nov 12, 2025

Volume	60
Average Volume	16,797
Open	313.00
Previous Close	313.00
Day's Range	313.00 - 313.00
52-Week Range	259.01 - 420.00
Beta	n/a
RSI	55.61
Earnings Date	Feb 17, 2026

About Kenvue

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other...

• Industry: Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2022
• Employees: 22,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: KVUE

Financial Performance

In 2024, Kenvue's revenue was $15.46 billion, an increase of 0.07% compared to the previous year's $15.44 billion. Earnings were $1.03 billion, a decrease of -38.10%.

Financial numbers in USD